Home
About
Overview
Sharing Data
ORCID
Help
History (3)
A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200?mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma.
Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus-Related Cervical Carcinoma.
Chicago Stroke Trials Consortium
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Chicago Stroke Trials Consortium
Overview
sponsor award id
U24NS107233
Biography
contributor
Principal Investigator
Time
start date
2018-08-15
end date
2028-11-30